23 May 2013
Keywords: array, gets, 3m, ph, ii, milestone, astrazeneca
Article | 25 September 2006
Colorado, USA-headquartered Array BioPharma says that it received a $3.0 million payment from Anglo-Swedish drug major AstraZeneca for achieving
a Phase ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 September 2006
22 May 2013
© 2013 thepharmaletter.com